Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blair Capitano

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|August 17, 2002
Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection modelDawei Xuan, Maryanne Banevicius, Blair Capitano, et al.
Therapeutic Drug Monitoring|December 6, 2008
Suboptimal aminoglycoside dosing in critically ill patientsRhonda S Rea, Blair Capitano, Robert Bies, et al.
Chemotherapy|June 24, 2004
Differential efficacy of clarithromycin in lung versus thigh infection modelsDana Maglio, Blair Capitano, Mary Anne Banevicius, et al.
Pharmacoeconomics|April 6, 2004
Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infectionsJoseph L Kuti, Srividya Kotapati, Peter Williams, et al.
International Journal of Antimicrobial Agents|May 4, 2004
Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistanceDana Maglio, Blair Capitano, Mary Anne Banevicius, et al.
Chest|March 10, 2004
Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adultsBlair Capitano, Holly M Mattoes, Eric Shore, et al.
International Journal of Antimicrobial Agents|August 21, 2007
Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?Sunil Bhat, Shigeki Fujitani, Brian A Potoski, et al.
Chemotherapy|May 16, 2002
Comparative pharmacokinetic and pharmacodynamic profile of piperacillin/tazobactam 3.375G Q4H and 4.5G Q6HHolly M Mattoes, Blair Capitano, Myo-Kyoung Kim, et al.
Pharmacotherapy|June 30, 2004
Meropenem administered as a prolonged infusion to treat serious gram-negative central nervous system infectionsBlair Capitano, David P Nicolau, Brian A Potoski, et al.
Pharmacotherapy|May 16, 2002
Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactamMyo-Kyoung Kim, Blair Capitano, Holly M Mattoes, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|August 17, 2002
Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection modelDawei Xuan, Maryanne Banevicius, Blair Capitano, et al.
Therapeutic Drug Monitoring|December 6, 2008
Suboptimal aminoglycoside dosing in critically ill patientsRhonda S Rea, Blair Capitano, Robert Bies, et al.
Chemotherapy|June 24, 2004
Differential efficacy of clarithromycin in lung versus thigh infection modelsDana Maglio, Blair Capitano, Mary Anne Banevicius, et al.
Pharmacoeconomics|April 6, 2004
Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infectionsJoseph L Kuti, Srividya Kotapati, Peter Williams, et al.
International Journal of Antimicrobial Agents|May 4, 2004
Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistanceDana Maglio, Blair Capitano, Mary Anne Banevicius, et al.
Chest|March 10, 2004
Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adultsBlair Capitano, Holly M Mattoes, Eric Shore, et al.
International Journal of Antimicrobial Agents|August 21, 2007
Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?Sunil Bhat, Shigeki Fujitani, Brian A Potoski, et al.
Chemotherapy|May 16, 2002
Comparative pharmacokinetic and pharmacodynamic profile of piperacillin/tazobactam 3.375G Q4H and 4.5G Q6HHolly M Mattoes, Blair Capitano, Myo-Kyoung Kim, et al.
Pharmacotherapy|June 30, 2004
Meropenem administered as a prolonged infusion to treat serious gram-negative central nervous system infectionsBlair Capitano, David P Nicolau, Brian A Potoski, et al.
Pharmacotherapy|May 16, 2002
Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactamMyo-Kyoung Kim, Blair Capitano, Holly M Mattoes, et al.
Pageof 3